NanoVibronix Inc (OQ:NAOV)

Business Focus: Medical Equipment, Supplies & Distribution

Nov 16, 2020 06:12 pm ET
NanoVibronix Reports Third Quarter 2020 Financial Results, Provides Business Update
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today reported its financial results for the quarter ended September 30, 2020 and provided a business update.
Oct 16, 2020 08:30 am ET
NanoVibronix Expands Offerings with Introduction of PainShield Plus®
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced the launch of the next generation of its ultrasound pain management device, PainShield Plus® for the treatment of m
Oct 08, 2020 09:00 am ET
NanoVibronix Receives Positive Nasdaq Listing Determination
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield®, and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that the Company has received formal notification that the Nasdaq Hearings Panel (the "Panel") has granted the Company's request for continued listing on The Nasdaq Capital Market pursuant to an extension through December 15, 2020, to evidence compliance with the minimum $2.5 million stockholders’ equity requirement set forth in Nasdaq Listing Rule 5550(b) for continued list
Jul 07, 2020 08:00 am ET
NanoVibronix Signs Two Year, Exclusive Distribution Agreement for PainShield
ELMSFORD, N.Y., July 7, 2020 /PRNewswire/ -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield®, and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that effective June 22, 2020, it has entered into a two-year exclusive agreement with Ultra Pain Products, Inc. ("UPPI") for the distribution of NanoVibronix's proprietary PainShield™ devices and components through and by Durable Medical Equipment (DME) Distributors throughout the United States. ...
Jun 16, 2020 08:00 am ET
NanoVibronix Fulfills its First Private Label Partnership with Medisana and Receives Award for PainShield PT 100 Quality
ELMSFORD, N.Y., June 16, 2020 /PRNewswire/ -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces Surface Acoustic Wave (SAW) based Ultrasonic Therapeutic Devices - the UroShield®, PainShield® and WoundShield®, today announced that its newly introduced PainShield PT 100 ultrasound therapy device has received the coveted Plus X Award 2020 in the categories of high quality, design, ease of use and functionality.  ...
Jun 01, 2020 08:00 am ET
NanoVibronix Expands License Agreement for UroShield® and PainShield™ with Existing Distributor to Include Canada and Turkey
ELMSFORD, N.Y., June 1, 2020 /PRNewswire/ -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield®, and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has expanded its license agreement with Ideal Medical International Limited to include exclusive rights to distribute the Company's UroShield® and PainShield® technologies in Canada and Turkey effective May 27, 2020.  ...
Apr 02, 2020 11:06 am ET
SANUWAVE Health Announces Exclusive Licensing of NanoVibronix, Inc. Surface Acoustic Wave Ultrasound Technology
via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) and NanoVibronix, Inc. have announced an exclusive worldwide license agreement for NanoVibronix’s surface acoustic wave ultrasound technology in the wound care market.  Under this...
Apr 02, 2020 08:00 am ET
NanoVibronix Announces License Agreement for WoundShield Product
ELMSFORD, N.Y., April 2, 2020 /PRNewswire/ -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield®, and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it signed a license agreement with Sanuwave Health, Inc. for the manufacture and delivery of its WoundShield technology.  ...
Apr 01, 2020 08:00 am ET
NanoVibronix Receives Reimbursement Approval from U.S. Centers for Medicare & Medicaid Services (CMS) for PainShield™
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the PainShield® Surface Acoustic Wave (SAW) Portable Ultra Sonic therapeutic device, today announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has...
Mar 27, 2020 09:41 am ET
NanoVibronix looks to expand use of its UroShield Due to the potential to impact comorbidities related to COVID-19 Crisis
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® Surface Acoustic Wave (SAW) Portable Ultra Sonic therapeutic device which attaches to an indwelling catheter and has been clinically proven to mitigate...
Dec 10, 2019 11:45 am ET
NanoVibronix, Inc. to Present at the Investor Summit on December 17th in Philadelphia
PHILADELPHIA, PA / ACCESSWIRE / December 10, 2019 / NanoVibronix, Inc. (NASDAQ:NAOV), will be presenting at this year's Investor Summit on December 17th in Philadelphia.
Sep 03, 2019 08:30 am ET
NanoVibronix and Marathon Medical to Provide PainShield to VA Hospitals and the Department of Justice
ELMSFORD, N.Y., Sept. 3, 2019 /PRNewswire/ -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the PainShield® Surface Acoustic Wave (SAW) Portable Ultra Sonic therapeutic device, announces on August 18th, 2019, PainShield, and PainShield Supplies were added to the Federal Supply Schedule through NanoVibronix' relationship with Marathon Medical, a Service Disabled Veteran Owned Small Business (SDVOSB) headquartered in Aurora, Colorado. Accordingly, Marathon Medical can now sell PainShield and related supplies to the Veterans Health Administration, the largest integr...
Aug 27, 2019 08:30 am ET
NanoVibronix Reports Significant Progress with a Leading Global Consumer Healthcare Company
ELMSFORD, N.Y., Aug. 27, 2019 /PRNewswire/ -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the PainShield® surface acoustic wave (SAW) device, today announced significant progress with a leading global consumer healthcare company, Medisana, which has resulted in an initial Original Equipment Manufacturing (OEM) purchase order. The Company will commence the manufacture of a specialized product for Medisana based on its PainShield® device called the PT-100. The product will be sold directly and exclusively via Medisana....
Jul 23, 2019 08:30 am ET
NanoVibronix Announces License Agreement with Ideal Medical International Limited for International Distribution of PainShield(R) and UroShield(R)
ELMSFORD, NY / ACCESSWIRE / July 23, 2019 / NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the PainShield® surface acoustic wave (SAW) device, which utilizes the Company’s proprietary and patented low intensity, SAW ultrasound technology, today announced that i
Jun 24, 2019 05:42 pm ET
NanoVibronix Announces Closing of $3.2 Million Private Placement
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the PainShield® surface acoustic wave (SAW) device, which utilizes the Company’s proprietary and patented low intensity, SAW ultrasound technology, today announced that it...
Jun 19, 2019 09:20 am ET
NanoVibronix Announces Presentation of PainShield(R) to HCPCS Workgroup at CMS
ELMSFORD, NY / ACCESSWIRE / June 19, 2019 / NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the PainShield® surface acoustic wave (SAW) device, which utilizes the Company's proprietary and patented low intensity, SAW ultrasound technology, announces that on June 12, 2019, the Company had the opportunity to present their signature product, PainShield® surface acoustic wave device, to the Healthcare Common Procedure Coding System (HCPCS) Workgroup at the Centers for Medicare &
Jun 14, 2019 09:00 am ET
NanoVibronix Announces Rescheduling of Annual Meeting of Stockholders
ELMSFORD, NY / ACCESSWIRE / June 14, 2019 / NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the PainShield® surface acoustic wave (SAW) device, which utilizes the Company's proprietary and patented low intensity, SAW ultrasound technology, announces that the Company's 2019 Annual Meeting of Stockholders, originally scheduled for 10:00 a.m. Eastern Time yesterday, June 13, 2019, was adjourned due to the lack of the requisite quorum. The meeting has been rescheduled for June 20,
Jun 05, 2019 08:30 am ET
NanoVibronix Announces Planned Launch of CBD Patch and Cream for PainShield® Designed to Amplify Therapeutic Effect
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the PainShield® surface acoustic wave (SAW) device, which utilizes the Company’s proprietary and patented low intensity, SAW ultrasound technology, today announced that it...
Jun 03, 2019 09:00 am ET
NanoVibronix Announces Planned Launch of CBD Patch and Cream for PainShield(R) Designed to Amplify Therapeutic Effect
- Combination of nanoparticle CBD-infused patch/cream and PainShield® intended as powerful alternative to opioids for treatment of pain- NanoVibronix partnering with Saralex Group for regulatory approval and global distribution
May 24, 2019 08:00 am ET
NanoVibronix Provides Business Update for the First Quarter of 2019
ELMSFORD, NY / ACCESSWIRE / May 24, 2019 / NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided a business update for the first quarter ended March 31, 2019.
Apr 02, 2019 08:00 am ET
NanoVibronix Provides Year-End Business Update
Reports on Commercial Progress for both PainShield® and UroShield®
Mar 25, 2019 09:00 am ET
NanoVibronix Announces Reimbursement Approvals for PainShield(R) in the U.S.
Reimbursement aligned with AHIP and CMS initiatives to help combat the opioid epidemic
Mar 20, 2019 08:00 am ET
NanoVibronix Announces Exclusive Agreement for Distribution of PainShield(R) and UroShield(R) in Italy
ELMSFORD, NY / ACCESSWIRE / March 20, 2019 / NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has entered into an exclusive agreement with N.B.A. medica s.r.l. to market and distribute NanoVibronix's PainShield® and UroShield in Italy.
Mar 08, 2019 09:00 am ET
NanoVibronix CEO to Present UroShield(R) at the U.S. National Institutes of Health's Catheter-Associated Urinary Tract Infections Technology Workshop
ELMSFORD, NY / ACCESSWIRE / March 8, 2019 / NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company utilizing its proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that CEO Brian Murphy will present UroShield® at the Catheter-Associated Urinary Tract Infections Technology Workshop hosted by National Institutes of Health (NIH) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) on Monday, March 11, 2019 at the NIH's Natcher Conference Center in Bethesda, Maryland.
Mar 07, 2019 08:30 am ET
NanoVibronix Reports Positive Interim Tennis Elbow Study Results Using PainShield(R)
ELMSFORD, NY / ACCESSWIRE / March 7, 2019 / NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced results of a study entitled, "The Effects of the NanoVibronix's PainShield® Surface Acoustic Waves on the Symptoms of Lateral Epicondylitis." The clinical study was conducted by Dr. David Lemak, a leading orthopedic surgeon with Birmingham Orthopedic and Sports Specialists.
Mar 04, 2019 08:30 am ET
NanoVibronix Launches New Consumer and Industry Focused Website Highlighting Advantages of PainShield, UroShield and WoundShield
ELMSFORD, NY / ACCESSWIRE / February 4, 2019 / NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has launched a new website (www.nanovibronix.com) designed to highlight the advantages of the Company's proprietary and patented low intensity surface acoustic wave (SAW) devices, including PainShield®, UroShield® and WoundShield®.
Feb 25, 2019 08:00 am ET
NanoVibronix Announces Publication of PainShield™ Trigeminal Neuralgia Study in the Journal of Anesthesiology and Pain Research
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced the publication of an independent study entitled, “The Effect of a...
Jan 11, 2019 08:00 am ET
NanoVibronix Enters Collaboration Agreement with Fritz Clinic to Offer PainShield® as an Alternative to Opioids for Pain Management
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that it has entered into a collaboration agreement with the Fritz...
Dec 27, 2018 08:00 am ET
NanoVibronix Announces Expanded Agreement with MDS Pharm Ltd. to Include Distribution of UroShield® in Israel
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has expanded its distribution agreement with MDS. Pharm Ltd.,...
Dec 20, 2018 08:00 am ET
NanoVibronix Signs Major Distributor in India for UroShield®
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced, in partnership with Morulaa HealthTech, NanoVibronix’s marketing...
Dec 18, 2018 09:25 am ET
NanoVibronix Signs with Exclusive Distributor in Switzerland for UroShield®
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has signed a new distribution agreement for UroShield® with...
Dec 11, 2018 09:01 am ET
NanoVibronix Announces Selection of Leading International Contract Manufacturer to Support Rapid Scale-up, Lower Price Points and Enhance Profitability
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has appointed Quasar as its contract manufacturer for the...
Dec 06, 2018 08:00 am ET
NanoVibronix Announces Publication of Study Measuring the Effect of Surface Acoustic Waves on Bacterial Load and Preventing Catheter-Associated Urinary Tract Infections
UroShield™ reduced Colony Forming Units (CFU) count from >- NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced the...
Nov 19, 2018 07:50 am ET
New Research: Key Drivers of Growth for Nanovibronix, Griffin Industrial Realty, Iteris, NAPCO Security Technologies, Nortech, and New Age Beverage — Factors of Influence, Major Initiatives and Sustai
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Nanovibronix, Inc. (NASDAQ:NAOV), Griffin Industrial Realty, Inc....
Nov 14, 2018 08:00 am ET
NanoVibronix Provides Business Update for the Third Quarter of 2018
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided a business update for the third quarter ended September 30, 2018....
Oct 22, 2018 04:47 pm ET
NanoVibronix to Present at Dawson James Securities 4th Annual Small Cap Growth Conference
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that Brian Murphy, Chief Executive Officer, will be presenting at...
Oct 22, 2018 04:12 pm ET
NanoVibronix CEO Brian Murphy and Former MLB Pitcher Bret Saberhagen to Appear Today on Varney & Co. on Fox Business to Discuss PainShield
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that Brian Murphy, CEO of NanoVibronix, and former MLB pitcher, Bret...
Aug 16, 2018 08:00 am ET
NanoVibronix Provides Business Update for the Second Quarter of 2018
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided a business update for the second quarter ended June 30, 2018. Brian...
Jul 24, 2018 07:30 am ET
NanoVibronix Reports Successful Trial Results for Use of PainShield™ in Patients with Trigeminal Neuralgia; Reinforces Potential as Alternative to Opioids and Surgical Interventions
NanoVibronix, Inc, (NASDAQ:NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced successful results for its PainShield™ device in treating patients...
Jun 05, 2018 07:00 am ET
NanoVibronix Announces Exclusive Agreement for Distribution of PainShield® and WoundShield® in Israel
NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has entered into an exclusive agreement with M.D.S. Pharm Ltd. to...
May 17, 2018 09:44 am ET
NanoVibronix Provides Business Update for the First Quarter 2018
NanoVibronix, Inc, (NASDAQ:NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided a business update for the first quarter of 2018. Brian Murphy, Chief...
May 09, 2018 07:00 am ET
NanoVibronix Partners with Fabrication Enterprises, Inc. for Distribution of PainShield® in the United States
NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has partnered with Fabrication Enterprises, Inc. to market and...
May 01, 2018 08:39 am ET
NanoVibronix to Present at the 3rd Annual Disruptive Growth & Healthcare Conference Hosted by RHK Capital and Reed Smith
NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that it will be presenting at the 3rd...
Apr 05, 2018 07:30 am ET
NanoVibronix Announces Instrumed Surgical as its Exclusive Canadian Distributor for UroShield(TM)
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has signed Instrumed Surgical of Mississauga, Ontario, Canada as...
Apr 02, 2018 07:00 am ET
NanoVibronix Provides Year-End 2017 Business Update and Files 10-K
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided a business update for the year ended December 31, 2017.Brian Murphy,...
Mar 21, 2018 03:40 pm ET
NanoVibronix CEO Brian Murphy and Former Yankees Pitcher Mariano Rivera Appear on Fox News Radio's The Brian Kilmeade Show to Discuss PainShield's Advantages and Potential to Reduce Opioid Use
NanoVibronix Inc. (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that Brian Murphy, CEO of NanoVibronix and former Yankees pitcher...
Mar 21, 2018 08:01 am ET
NanoVibronix CEO Brian Murphy and Former Yankees Pitcher Mariano Rivera to Appear on Fox Business Network's Mornings with Maria to Discuss the Role of PainShield in Fighting the Opioid Epidemic
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that Brian Murphy, CEO of NanoVibronix and former Yankees pitcher...
Mar 01, 2018 07:30 am ET
NanoVibronix Announces Positive Response to UroShield(TM) Presentation at the Infection Prevention and Control 2018 London Conference
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology today announced that Dr. Harold Jacob, M.D., Chief Medical Officer of NanoVibronix, led...
Jan 22, 2018 07:30 am ET
NanoVibronix to Present at the 14th Annual Noble Capital Markets Investor Conference
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, will present at NobleCon14 - Noble Capital Markets' Fourteenth Annual Investor...
Jan 19, 2018 01:06 pm ET
NanoVibronix CEO Brian Murphy Appears on Varney & Co. on Fox Business; Comments on Role of PainShield in Fighting Opioid Epidemic
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that Brian Murphy, CEO of NanoVibronix, appeared as a guest on Varney...
Jan 18, 2018 10:00 am ET
Dec 21, 2017 09:41 am ET
NanoVibronix CEO Brian Murphy Provides Business Update Letter to Shareholders
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided the following business update and letter to shareholders from its Chief...
Dec 20, 2017 09:00 am ET
NanoVibronix Announces Morulaa HealthTech as its Regulatory & Marketing Partner in India
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has signed Morulaa HealthTech as its regulatory and marketing...
Dec 14, 2017 07:30 am ET
NanoVibronix Announces IMS Ultrasound (UK) Ltd as its Exclusive UK Distributor for UroShield(TM) Following Successful Interim Trial Results
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has signed IMS Ultrasound (UK) Ltd as its exclusive distributor...
Dec 06, 2017 12:20 pm ET
Wildfire Forces Cancellation of LD Micro Conference
Presentations Canceled for Celsius Holdings, Inc., GSI Technology, Inc., PCM, Inc., Simulations-Plus, ADOMANI, Inc., HUTN, Inc., NanoVibronix, Inc. and WidePoint Corp.
Dec 05, 2017 08:00 am ET
NanoVibronix Announces Exclusive UK Distributor for PainShield(TM) Providing Patients an Alternative to Opioids and Surgery
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has signed BHR Pharmaceuticals Ltd., a leading distributor of...
Nov 29, 2017 07:30 am ET
NanoVibronix Reports Successful Interim Trial Results for Use of PainShield(TM) in Patients with Trigeminal Neuralgia; Represents Potential Alternative to Opioid and Surgical Interventions
NanoVibronix Inc. (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced successful interim trial results for its PainShield™ device in treating...
Nov 14, 2017 07:50 am ET
NanoVibronix to Commence Trial of Anti-Aging Device in Collaboration with Global Cosmetics Company
NanoVibronix, Inc. (NASDAQ: NAOV),a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced the execution of a collaborative agreement to conduct a single-center...
Nov 08, 2017 07:30 am ET
NanoVibronix Announces Successful Interim Trial Results for UroShield(TM)
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave technology, today announced successful interim trial results for its UroShield™ device. UroShield™ is an...
Nov 07, 2017 10:13 am ET
NanoVibronix Announces Closing of $6,000,000 Public Offering
NanoVibronix, Inc. ("NanoVibronix" or the "Company") (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave technology, today announced the closing of an underwritten public...
Nov 01, 2017 09:53 pm ET
NanoVibronix Announces Pricing of $6,000,000 Public Offering
NanoVibronix, Inc. ("NanoVibronix" or the "Company") (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave technology, today announced the pricing of an underwritten public...
Jul 12, 2017 07:30 am ET
NanoVibronix Announces Successful Interim Trial Results for UroShield(TM)
NanoVibronix, Inc, (OTCQB: NAOV ), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave technology, today announced successful interim trial results for UroShield™. UroShield™ is an...
May 26, 2017 09:00 am ET
IDW Media Holdings Names Stephen R. Brown to Board of Directors
IDW Media Holdings, Inc. (OTCQX: IDWM) is pleased to announce that, on May 22, 2017, Stephen R. Brown joined its Board of Directors. Since October 2016, Mr. Brown has served as the President of GMA Fund, LLC, a specialty finance company, and, since February 2015, has served as the Chief Financial Officer of Nanovibronix, Inc. (OTCBB: NAOV). In addition, since 2009, Mr. Brown has been the managing partner of The McGuffin Group Financial, a financial consulting firm concentrating on advising early-stage companies.
Mar 09, 2017 07:30 am ET
US Patent and Trademark Office Grants Patent to NanoVibronix for Surface Acoustic Wave Technology
NanoVibronix, Inc. (OTCQB: NAOV),a medical device company, today announced that it has been granted a patent by the United States Patent and Trademark Office entitled, "System and Method for Surface Acoustic Wave Treatment of Skin," with a term...
Jan 09, 2017 07:30 am ET
NanoVibronix Announces Abstract Acceptance and Presentation at the European Association of Urology's 32nd Anniversary EAU Congress
NanoVibronix, Inc, (OTCQB: NAOV), a medical device company, today announced that its abstract, entitled "Surface acoustic waves prevent bacterial colonization in indwelling urinary catheters," has been accepted for presentation at the European...
Dec 28, 2016 07:30 am ET
NanoVibronix Receives Health Canada Approval to Sell WoundShield(TM) in Canada
NanoVibronix, Inc. (OTCQB: NAOV), a medical device company, today announced that it has received clearance to sell the WoundShield™ in Canada. The WoundShield™ system is a novel, patch-based therapeutic ultrasound device that facilitates soft tissue...
Dec 22, 2016 07:30 am ET
NanoVibronix Reports Progress on Three Clinical Trials
NanoVibronix, Inc., (OTCQB: NAOV), a medical device company, today provided an update on three significant clinical trials for its PainShield™, UroShield™ and TrachShield™ devices. Studies are underway in the U.S. and in Israel in order to...
Nov 15, 2016 07:00 am ET
NanoVibronix Provides Third Quarter 2016 Business Update
NanoVibronix, Inc. (OTCQB: NAOV), a medical device company, today has issued a business update on the company's patented low intensity surface acoustic wave technology for pain management, wound healing and other indications.Brian Murphy, Chief...
Oct 20, 2016 07:30 am ET
NanoVibronix Expands Senior Management Team and Board of Directors
NanoVibronix, Inc. (OTCQB: NAOV), a medical device company, today announced an expansion of the senior management team and Board of Directors. The Company appointed Brian M. Murphy as Director and Chief Executive Officer and Christopher M. Fashek as...
Sep 28, 2016 07:30 am ET
NanoVibronix Announces Distribution Agreement With Mano Equestrian Services (PTE) LTD in Singapore for Equine PainShield(R)
NanoVibronix, Inc, (OTCQB: NAOV),a medical device company, today announced a distribution agreement with Mano Equestrian Services (PTE) LTD ("Mano") to market and distribute Equine PainShield® in Singapore. Mano's distribution network covers...
Sep 06, 2016 07:30 am ET
NanoVibronix Receives Health Canada Approval to Sell UroShield(TM) in Canada
NanoVibronix, Inc, (OTCQB: NAOV), a medical device company, today announced that NanoVibronix has received clearance to sell the UroShield™ in Canada. UroShield™ is effective in preventing Urinary Tract Infections (UTI) in patients with indwelling...
Aug 02, 2016 07:30 am ET
Retired NFL Quarterback Vinny Testaverde Endorses NanoVibronix's SPORT Painshield(TM)
NanoVibronix, Inc, (OTCQB: NAOV), a medical device company, announced today that Vinny Testaverde, retired quarterback who played 21 seasons in the NFL and Heisman trophy winner, has endorsed NanoVibronix's SPORT Painshield™ for relief of joint and...
Mar 30, 2016 09:00 am ET
NanoVibronix Provides Business Update on Its Proprietary and Patented Low Intensity Surface Acoustic Wave Technology That Targets Wound Healing and Pain Therapy
NanoVibronix, Inc, (OTCQB: NAOV), a medical device company, today has issued a business update on the company's patented low intensity surface acoustic wave technology for pain management, wound healing and other indications.William Stern, PhD,...
Mar 22, 2016 07:30 am ET
Israeli Patent Office Issues Notice of Allowance to NanoVibronix Allowing All Claims of Patent Application for System and Method for Surface Acoustic Wave Treatment of Skin
NanoVibronix, Inc, (OTCQB: NAOV), a medical device company, has announced that the Israeli Patent Office has issued a notice of allowance for our system and method for surface acoustic wave treatment of skin. The patent will be granted following...
Feb 25, 2016 01:18 pm ET
NanoVibronix Announces Favorable Response to Presentation at the American Academy of Pain Medicine 32nd Annual Meeting at the Palms Springs Convention Center in California
NanoVibronix, Inc, (OTCQB: NAOV), developer of the patented low intensity surface acoustic wave technology for pain management, wound healing and other indications, today announced that its PainShield®, for chronic and acute pain and sports...
Feb 18, 2016 02:33 pm ET
NanoVibronix to Present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference at the Ritz in South Beach
NanoVibronix, Inc., (OTCQB: NAOV), a medical device company, today announced that William Stern, PhD, Chief Executive Officer of NanoVibronix will present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.